Clinical Trial: To Evaluate the Impact of MRSA Nasal Screen Implementation.

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748143) titled 'To Evaluate the Impact of MRSA Nasal Screen Implementation.' on June 08.

Brief Summary: To evaluate the impact of MRSA nasal screen implementation on duration of therapy and cost associated with vancomycin use.

Study Start Date: Oct. 01, 2019

Study Type: OBSERVATIONAL

Condition: MRSA

Intervention: OTHER: Duration of therapy

The final data will then be compared to determine if the duration of therapy and cost after implementation of the MRSA nasal screen if significantly different from before the implementation of the MRSA nasal screen.

OTHER: Direct Cost

Direct costs of vancomycin for each treatment arm (in US dollars).

OTH...